201 related articles for article (PubMed ID: 1964667)
1. Mode of action of unfractionated and low molecular weight heparins on the generation of thrombin in plasma.
Hemker HC; Béguin S
Haemostasis; 1990; 20 Suppl 1():81-92. PubMed ID: 1964667
[TBL] [Abstract][Full Text] [Related]
2. An approach to assigning in vitro potency to unfractionated and low molecular weight heparins based on the inhibition of prothrombin activation and catalysis of thrombin inhibition.
Ofosu FA; Smith LM; Anvari N; Blajchman MA
Thromb Haemost; 1988 Oct; 60(2):193-8. PubMed ID: 2851191
[TBL] [Abstract][Full Text] [Related]
3. Mode of action of enoxaparin in plasma.
Béguin S; Hemker HC
Acta Chir Scand Suppl; 1990; 556():51-6. PubMed ID: 1963017
[TBL] [Abstract][Full Text] [Related]
4. Comparative inhibition of LPS-activated human monocyte-induced thrombin generation by unfractionated heparin and low molecular weight heparins.
Nguyên P; Rémy MG; Potron G
Haemostasis; 1999; 29(6):301-9. PubMed ID: 10844403
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4).
Padilla A; Gray E; Pepper DS; Barrowcliffe TW
Br J Haematol; 1992 Oct; 82(2):406-13. PubMed ID: 1329921
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for the antithrombotic activity in man of low molecular weight heparins (LMWHs).
Samama MM; Bara L; Gerotziafas GT
Haemostasis; 1994; 24(2):105-17. PubMed ID: 7959358
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic activity and its relationship to in vitro anticoagulant effects.
Gray E; Padilla A; Barrowcliffe TW
Haemostasis; 1993 Mar; 23 Suppl 1():99-102. PubMed ID: 8388358
[TBL] [Abstract][Full Text] [Related]
8. Determination of the levels of unfractionated and low-molecular-weight heparins in plasma: their effect on thrombin-mediated feedback reactions in vivo. Preliminary results after subcutaneous injection.
Hemker HC; Béguin S; Bendetowicz AV; Wielders S
Haemostasis; 1991; 21(4):258-72. PubMed ID: 1665467
[TBL] [Abstract][Full Text] [Related]
9. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
Meddahi S; Bara L; Fessi H; Samama MM
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.
Verstraete M
Drugs; 1990 Oct; 40(4):498-530. PubMed ID: 1964634
[TBL] [Abstract][Full Text] [Related]
12. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
Peyrou V; Béguin S; Boneu B; Hemker HC
Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies of heparin cofactor activity toward antithrombin III and heparin cofactor II, and antithrombin III affinity between low molecular weight heparin and unfractionated heparin.
Shimotori T; Sakuragawa N
Semin Thromb Hemost; 1990 Oct; 16 Suppl():71-6. PubMed ID: 1962909
[TBL] [Abstract][Full Text] [Related]
14. The effect of subcutaneous injection of unfractionated and low molecular weight heparin on thrombin generation in platelet rich plasma--a study in human volunteers.
Bendetowicz AV; Kai H; Knebel R; Caplain H; Hemker HC; Lindhout T; Béguin S
Thromb Haemost; 1994 Nov; 72(5):705-12. PubMed ID: 7900078
[TBL] [Abstract][Full Text] [Related]
15. New data on the pharmacology of heparin and low molecular weight heparins.
Samama MM; Bara L; Gouin-Thibault I
Drugs; 1996; 52 Suppl 7():8-14; discussion 14-5. PubMed ID: 9042555
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of intrinsic prothrombinase and its generation by heparin and four derivatives in prothrombin poor plasma.
Bendetowicz AV; Bara L; Samama MM
Thromb Res; 1990 Jun; 58(5):445-54. PubMed ID: 2164262
[TBL] [Abstract][Full Text] [Related]
17. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of synthetic pentasaccharide, low-molecular-weight heparin, unfractionated heparin and recombinant hirudin on the generation of factor VIIa and prothrombin activation after coagulation of human plasma.
Gerotziafas GT; Bara L; Bloch MF; Makris PE; Samama MM
Blood Coagul Fibrinolysis; 1998 Oct; 9(7):571-80. PubMed ID: 9863704
[TBL] [Abstract][Full Text] [Related]
19. From unfractionated heparins to low molecular weight heparins.
Hirsh J
Acta Chir Scand Suppl; 1990; 556():42-50. PubMed ID: 1705072
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]